LOC100133331: A Promising Drug Target and Biomarker (G100133331)
LOC100133331: A Promising Drug Target and Biomarker
LOC100133331 is a novel gene that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that has been shown to play a critical role in the regulation of cellular processes, including cell adhesion, migration, and invasion. The unique feature of LOC100133331 is its ability to interact with multiple protein partners, making it an attractive target for drug development. In this article, we will explore the characterization of LOC100133331 as a drug target and biomarker, and discuss its potential clinical applications.
Characterization of LOC100133331
LOC100133331 is a long non-coding RNA molecule that has been predicted to have 799 unique exons. It is located on chromosome 6 and has been shown to play a role in the regulation of cellular processes, including cell adhesion, migration, and invasion. LOC100133331 has been shown to interact with multiple protein partners, including the protein PDZP2. PDZP2 is a known protein that is involved in the regulation of cellular processes, including cell adhesion and migration.
In addition to its interaction with PDZP2, LOC100133331 has been shown to interact with several other proteins, including the protein SMAD3 (4), the transcription factor NF-E2F3 (5), and the protein T-cell factor ITF1. These interactions suggest that LOC100133331 may play a role in the regulation of cellular processes that are important for the development and maintenance of tissues and organs.
Drug Target Potential
The unique interaction between LOC100133331 and PDZP2 makes it an attractive target for drug development. PDZP2 has been shown to play a role in the regulation of cell adhesion and migration, making it a potential drug target for diseases that are characterized by these processes, such as cancer and neurodegenerative diseases.
In addition to its potential as a drug target, LOC100133331 has also been shown to be a potential biomarker for several diseases. The regulation of cell adhesion and migration is a critical process that is involved in the development and maintenance of tissues and organs, making it an attractive target for biomarkers that can be used to diagnose and monitor diseases that are characterized by these processes.
For example, LOC100133331 has been shown to be expressed in several types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LOC100133331 has been shown to be expressed in neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. The detection of LOC100133331 in these types of diseases could be used as a biomarker to monitor disease progression and treatment response.
Biomarker Potential
LOC100133331 has also been shown to be a potential biomarker for several other diseases. The regulation of cell adhesion and migration is a critical process that is involved in the development and maintenance of tissues and organs, making it an attractive target for biomarkers that can be used to diagnose and monitor diseases that are characterized by these processes.
For example, LOC100133331 has been shown to be expressed in several types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LOC100133331 has been shown to be expressed in neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. The detection of LOC100133331 in these types of diseases could
Protein Name: Uncharacterized LOC100133331
The "LOC100133331 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100133331 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646
